These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 16540035
61. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension. Siciliano M, Mettimano M, Dondolini-Poli A, Ballarin S, Migneco A, Annese R, Fazzari L, Fedeli P, Montebelli MR, Zuppi C, Savi L. Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933 [Abstract] [Full Text] [Related]
62. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study]. Martín-Rioboó E, García Criado E, Pérula De Torres LA, Cea-Calvo L, Anguita Sánchez M, López Granados A, Ureña Fernández T, García Matarín L, Molina Díaz R, en representación del Grupo de Hipertensión Arterial de la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFyC) y de los investigadores del estudio PREHVIA. Med Clin (Barc); 2009 Feb 28; 132(7):243-50. PubMed ID: 19248873 [Abstract] [Full Text] [Related]
63. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. Marín R, Rodríguez P, Tranche S, Redón J, Morales-Olivas F, Galgo A, Brito MA, Mediavilla J, Lozano JV, Filozof C, MAGAL group. J Am Soc Nephrol; 2006 Dec 28; 17(12 Suppl 3):S178-88. PubMed ID: 17130259 [Abstract] [Full Text] [Related]
65. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. Smilde TD, Zuurman MW, Hillege HL, van Veldhuisen DJ, van Gilst WH, van der Steege G, Voors AA, Kors JA, de Jong PE, Navis G. Am J Hypertens; 2007 Oct 28; 20(10):1097-103. PubMed ID: 17903694 [Abstract] [Full Text] [Related]
66. Influence of cigarette smoking on the electrocardiographic diagnosis of left ventricular hypertrophy in arterial hypertension. Schillaci G, Verdecchia P, Sacchi N, Vignai E, Benemio G, Porcellati C. G Ital Cardiol; 1999 Jan 28; 29(1):34-8. PubMed ID: 9987045 [Abstract] [Full Text] [Related]
67. Cardiovascular risk factors are not treated to target in hypertensive patients in primary care. Nieburg I, Kahan T. Blood Press; 2010 Jun 28; 19(3):176-81. PubMed ID: 20429693 [Abstract] [Full Text] [Related]
68. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension in public and private primary care settings: the HiHi study. Dennison CR, Peer N, Lombard CJ, Kepe L, Levitt NS, Steyn K, Hill MN. Ethn Dis; 2007 Jun 28; 17(3):477-83. PubMed ID: 17985501 [Abstract] [Full Text] [Related]
70. [Association between hypertensive left ventricular hypertrophy and cardiovascular events in adult Beijing residents: a cohort study]. Li Y, Zhao D, Liu J, Li CF, Guo W, Chen CH, Hao P, Sun JY, Qin LP, Wang W. Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov 28; 36(11):1037-42. PubMed ID: 19102921 [Abstract] [Full Text] [Related]
71. [Control of hypertension in elderly patients receiving primary care in Spain]. Rodríguez Roca GC, Artigao Ródenas LM, Llisterri Caro JL, Alonso Moreno FJ, Banegas Banegas JR, Lou Arnal S, Pérez Llamas M, Raber Béjah A, Pacheco López R. Rev Esp Cardiol; 2005 Apr 28; 58(4):359-66. PubMed ID: 15847732 [Abstract] [Full Text] [Related]
74. A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients. Fahey TP, Peters TJ. Br J Gen Pract; 1996 Nov 28; 46(412):655-9. PubMed ID: 8978111 [Abstract] [Full Text] [Related]
75. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ. J Am Soc Nephrol; 2005 Jun 28; 16(6):1803-10. PubMed ID: 15857925 [Abstract] [Full Text] [Related]
77. [Associations between arterial hypertension and other cardiovascular risk factors in subjects over 65 years of age]. Fiandra U, Bo M, Fonte G, Casoli G, Ferrario E. Recenti Prog Med; 1995 Apr 28; 86(4):147-54. PubMed ID: 7617957 [Abstract] [Full Text] [Related]
78. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study. Bruno G, Giunti S, Bargero G, Ferrero S, Pagano G, Perin PC. Diabet Med; 2004 Aug 28; 21(8):823-8. PubMed ID: 15270784 [Abstract] [Full Text] [Related]
79. The prevalence of left ventricular hypertrophy and associated factors in a Thai population. Sriratanasathavorn C, Bhuripanyo K, Mahanonda N, Leowattana W, Ruangratanaamporn O, Chotinaiwattarakul C, Krittayapong R, Kangkagate C, Chaitiraphan S. J Med Assoc Thai; 2000 Nov 28; 83 Suppl 2():S218-22. PubMed ID: 11194018 [Abstract] [Full Text] [Related]
80. Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension. Monfared A, Salari A, Mirbolok F, Momeni M, Shafighnia S, Shakiba M, Sheikholeslami A. Iran J Kidney Dis; 2013 May 28; 7(3):192-7. PubMed ID: 23689150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]